Guggenheim Capital’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7,808
Closed -$1.03M 2267
2018
Q4
$1.03M Buy
7,808
+3,528
+82% +$452K 0.01% 1375
2018
Q3
$572K Buy
4,280
+1,560
+57% +$234K ﹤0.01% 1907
2018
Q2
$433K Sell
2,720
-260
-9% -$38.6K ﹤0.01% 2029
2018
Q1
$426K Buy
2,980
+430
+17% +$58.8K ﹤0.01% 2426
2017
Q4
$339K Sell
2,550
-2,136
-46% -$273K ﹤0.01% 2463
2017
Q3
$582K Buy
4,686
+680
+17% +$93.6K ﹤0.01% 2339
2017
Q2
$563K Buy
4,006
+352
+10% +$44K ﹤0.01% 2364
2017
Q1
$411K Sell
3,654
-9
-0.2% -$1.05K ﹤0.01% 2444
2016
Q4
$386K Sell
3,663
-17
-0.5% -$1.83K ﹤0.01% 2509
2016
Q3
$465K Buy
3,680
+1,141
+45% +$145K ﹤0.01% 2408
2016
Q2
$351K Sell
2,539
-485
-16% -$64.2K ﹤0.01% 2494
2016
Q1
$419K Sell
3,024
-4,171
-58% -$572K ﹤0.01% 2438
2015
Q4
$1.16M Sell
7,195
-7,310
-50% -$1.13M ﹤0.01% 2023
2015
Q3
$1.94M Sell
14,505
-5,494
-27% -$717K 0.01% 1619
2015
Q2
$2.29M Buy
19,999
+541
+3% +$64.7K 0.01% 1655
2015
Q1
$2.32M Buy
19,458
+65
+0.3% +$8.66K 0.01% 1648
2014
Q4
$2.83M Buy
19,393
+6,095
+46% +$765K 0.01% 1477
2014
Q3
$1.75M Sell
13,298
-171
-1% -$22.5K ﹤0.01% 1857
2014
Q2
$1.69M Sell
13,469
-1,727
-11% -$223K ﹤0.01% 1945
2014
Q1
$2.44M Sell
15,196
-14,581
-49% -$2.4M 0.01% 1624
2013
Q4
$4M Buy
29,777
+19,248
+183% +$2.47M 0.01% 1230
2013
Q3
$1.14M Sell
10,529
-10,255
-49% -$1.11M ﹤0.01% 2019
2013
Q2
$1.76M Buy
+20,784
New +$1.86M 0.01% 1612

Guggenheim Capital's ATHN Position: Q1 2019 in Review

Guggenheim Capital sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 7,808 shares — an estimated $1.03M sold.

Guggenheim Capital first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $4M in Q4 2013. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Guggenheim Capital reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Guggenheim Capital sold 7,808 Athenahealth, Inc. shares in Q1 2019, an estimated $1.03M.
  • Guggenheim Capital first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Guggenheim Capital's Athenahealth, Inc. position peaked at $4M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Guggenheim Capital's 13F filing for Q1 2019, filed 15 May 2019.